$SDGR
Schrodinger, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · New York, NY
SDGR chart
What traders are saying about $SDGR
Latest postsSchrodinger, Inc. news
- Schrodinger's Action Cam: Here's What The Insta360/GoPro Lawsuit Decision Means
RideApart.com ·
- Is Schrödinger (SDGR) Still Below Fair Value After Strong Q3 Revenue Growth?
Yahoo Finance ·
- Raised Guidance Could Change The Case For Schrödinger Stock (SDGR)
Yahoo Finance ·
- Schrödinger (SDGR) Stock Could Be 30% Undervalued Following Bunsen AI Progress
Simply Wall St ·
- TD Cowen maintains Schrodinger at Buy, raises price target to $36 from $31
TradingView ·
- Schrödinger, Inc. Q3 2026 Earnings Call Summary
app.moby.co ·
- Schrodinger, Inc. Stock 12‑Month Price Target Raised to $29, Implies 2% Upside
TradingView ·
- Key facts: Q3 beat; Novartis deal expands; analysts lift target
TradingView ·
- Schrodinger, Inc. Stock 12‑Month Price Target Raised to $27.29, Implies 4% Downside
TradingView ·
- Schrodinger Inc (SDGR) (Q3 2026) Earnings Call Highlights: Raised Guidance and Strong ACV ...
Yahoo Finance ·
- What Schrodinger (SDGR) Said on Its Q3 Earnings Call
marketbeat.com ·
- Science Gallery Bengaluru's quantum program features 'Mr. Tomkins meets Schrodinger'
NewsBytes ·
Schrodinger, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $255.9M | $207.5M | $216.7M | $181.0M |
| Net income | -$103.3M | -$187.1M | $40.7M | -$149.2M |
| Diluted EPS | $-1.41 | $-2.57 | $0.54 | $-2.10 |
| Total assets (year end) | $726.2M | $823.2M | $803.0M | $688.6M |
| Cash and equivalents (year end) | $230.5M | $147.3M | $155.3M | $90.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Schrodinger, Inc.
- Ticker
- SDGR (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- New York, NY
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1490978
Frequently asked questions
What exchange is Schrodinger, Inc. listed on?
Schrodinger, Inc. trades on the Nasdaq under the ticker symbol SDGR.
What industry is Schrodinger, Inc. in?
Schrodinger, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Schrodinger, Inc. headquartered?
Schrodinger, Inc.'s business address on file with the SEC is in New York, NY.
When does Schrodinger, Inc.'s fiscal year end?
Schrodinger, Inc.'s fiscal year ends on December 31.
How much revenue did Schrodinger, Inc. report?
Schrodinger, Inc. reported $255.9M in revenue for calendar year 2025, according to its SEC filings.